2269:HKG
WuXi Biologics (Cayman) Inc
48,20 HK$
arrow_downward
-0,90%(-0,44) 1K
16-okt, 16:08:14 (GMT+8) · HKD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto2269 tikeri uchun statistika yaratilmoqda...
Ochish
49,98 HK$
Yuqori
50,85 HK$
Past
45,82 HK$
Bozor kapitali
198,43 mlrd
Oʻrtacha hajm
30,42 mln
Hajmi
55,18 mln
P/E koeffitsiyenti
34,48
52 haftalik eng yuqori
58,00 HK$
52 haftalik eng past
28,48 HK$
Aksiya boʻyicha daromad
1,40 HK$
Muomaladagi aksiyalar
1,23 mlrd
Xodimlar soni
15 ming
Ochish
49,98 HK$
Yuqori
50,85 HK$
Past
45,82 HK$
Bozor kapitali
198,43 mlrd
Oʻrtacha hajm
30,42 mln
Hajmi
55,18 mln
P/E koeffitsiyenti
34,48
52 haftalik eng yuqori
58,00 HK$
52 haftalik eng past
28,48 HK$
Aksiya boʻyicha daromad
1,40 HK$
Muomaladagi aksiyalar
1,23 mlrd
Xodimlar soni
15 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Yahoo Finance
·
55 daqiqa oldin
SK hynix (NasdaqGS:SKHY) Seeks US Clearance For China Chip Gear Plan
The Motley Fool
·
10 daqiqa oldin
The 10-Year Treasury Is Above 5% for the First Time in Almost 20 Years. History Says This Is How the S&P 500 Index Will Perform Over the Next 12 Months.
Simply Wall Street
·
29 daqiqa oldin
What Ambarella Doubters Saw Before The Drop
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
WuXi Biologics (Cayman) Inc haqida
CEOZhisheng Chen
Xodimlar soni14,7 ming
Asos solingan2010
Bosh ofislar-
Sektor-
Veb-saytwuxibiologics.com